Title : Maintenance Rucaparib Controls Some Pancreatic Cancers.

Pub. Date : 2019 Jun

PMID : 30940721






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In an interim analysis, the targeted PARP inhibitor rucaparib showed encouraging signs of disease control when used as a maintenance therapy for patients with platinum-sensitive advanced pancreatic cancer and a pathogenic mutation in BRCA1, BRCA2, or PALB2. Platinum collagen type XI alpha 2 chain Homo sapiens